| Name | Title | Contact Details |
|---|
BMEYE - Cardiovascular Intelligence is a Louisville, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Global Clinical Trials is a Princeton, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Clinisys is a Bridgewater, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Maui Behavioral Health Resources is an umbrella agency of three non-profit organizations that provide a continuum of care for more than 3,000 people and families a year affected by behavioral health issues.
Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.